Myriad Genetics (MYGN) Short Interest Ratio & Short Volume → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free MYGN Stock Alerts $21.40 -0.09 (-0.42%) (As of 03/27/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Myriad Genetics Short Interest DataCurrent Short Volume4,800,000 sharesPrevious Short Volume4,000,000 sharesChange Vs. Previous Month+20.00%Dollar Volume Sold Short$101.57 millionShort Interest Ratio / Days to Cover7.5Last Record DateMarch 15, 2024Outstanding Shares89,880,000 sharesPercentage of Shares Shorted5.34%Today's Trading Volume505,033 sharesAverage Trading Volume751,732 sharesToday's Volume Vs. Average67% Short Selling Myriad Genetics ? Sign up to receive the latest short interest report for Myriad Genetics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMYGN Short Interest Over TimeMYGN Days to Cover Over TimeMYGN Percentage of Float Shorted Over Time Ad DTIWarning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…Watch the presentation here Myriad Genetics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20244,800,000 shares $101.57 million +20.0%N/A7.5 $21.16 2/29/20244,000,000 shares $83.72 million +8.1%N/A6 $20.93 2/15/20243,700,000 shares $87.28 million -0.3%N/A5.8 $23.59 1/31/20243,710,000 shares $79.36 million -2.9%N/A5.4 $21.39 1/15/20243,820,000 shares $75.90 million -10.3%6.0%5.4 $19.87 12/31/20234,260,000 shares $81.54 million -14.8%N/A6.4 $19.14 Get the Latest News and Ratings for MYGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Myriad Genetics and its competitors with MarketBeat's FREE daily newsletter. 12/15/20235,000,000 shares $103.70 million +4.4%N/A7.4 $20.74 11/30/20234,790,000 shares $91.44 million -2.2%N/A7.4 $19.09 11/15/20234,900,000 shares $85.36 million -14.8%N/A8 $17.42 10/31/20235,750,000 shares $89.59 million +4.0%N/A10.4 $15.58 10/15/20235,530,000 shares $80.41 million +11.9%N/A10.6 $14.54 9/30/20234,940,000 shares $79.24 million +1.7%N/A9.5 $16.04 9/15/20234,860,000 shares $80.72 million +9.0%N/A9.7 $16.61 8/31/20234,460,000 shares $79.61 million +15.0%N/A9.2 $17.85 8/15/20233,880,000 shares $68.60 million -2.8%N/A7.5 $17.68 7/31/20233,990,000 shares $89.18 million -5.5%N/A7.6 $22.35 7/15/20234,220,000 shares $94.95 million +3.9%N/A8 $22.50 6/30/20234,060,000 shares $94.11 million -0.5%N/A7.3 $23.18 6/15/20234,080,000 shares $93.60 million -3.3%N/A7.3 $22.94 5/31/20234,220,000 shares $93.09 million +11.9%N/A7.2 $22.06 5/15/20233,770,000 shares $70.95 million +2.5%N/A6.1 $18.82 4/30/20233,680,000 shares $78.35 million -1.6%N/A6 $21.29 4/15/20233,740,000 shares $83.29 million -25.9%N/A6.2 $22.27 3/31/20235,050,000 shares $117.31 million -2.7%N/A8.4 $23.23 3/15/20235,190,000 shares $121.08 million +15.9%N/A7.4 $23.33 2/28/20234,480,000 shares $84.76 million +10.6%N/A6.1 $18.92 2/15/20234,050,000 shares $77.96 million +22.7%N/A5.9 $19.25 1/31/20233,300,000 shares $65.08 million +2.8%N/A4.6 $19.72 1/15/20233,210,000 shares $59.93 million -9.6%N/A4.3 $18.67 12/30/20223,550,000 shares $51.51 million -8.3%N/A4.8 $14.51 12/15/20223,870,000 shares $65.52 million +13.5%N/A5.9 $16.93 11/30/20223,410,000 shares $69.09 million -16.0%N/A6 $20.26 11/15/20224,060,000 shares $84.77 million +5.5%N/A7.4 $20.88 10/31/20223,850,000 shares $79.85 million +1.1%N/A7.3 $20.74 10/15/20223,810,000 shares $71.21 million +0.8%N/A7.7 $18.69 9/30/20223,780,000 shares $72.12 million -3.8%N/A7.3 $19.08 9/15/20223,930,000 shares $84.57 million +1.6%N/A7.7 $21.52 8/31/20223,870,000 shares $86.46 million -7.9%N/A7.3 $22.34 8/15/20224,200,000 shares $117.10 million +15.4%N/A7.7 $27.88 7/31/20223,640,000 shares $96.02 million -16.3%4.7%6.3 $26.38The AI Defense Stock Set to Soar (Ad)To protect our interests, The Pentagon has partnered with this small AI defense contractor - creating some of the most powerful AI defenses ever made.Here's how you can invest >>> MYGN Short Interest - Frequently Asked Questions What is Myriad Genetics' current short interest? Short interest is the volume of Myriad Genetics shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 4,800,000 shares of MYGN short. Learn More on Myriad Genetics' current short interest. What is a good short interest ratio for Myriad Genetics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MYGN shares currently have a short interest ratio of 8.0. Learn More on Myriad Genetics's short interest ratio. Which institutional investors are shorting Myriad Genetics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Myriad Genetics: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Myriad Genetics' short interest increasing or decreasing? Myriad Genetics saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 4,800,000 shares, an increase of 20.0% from the previous total of 4,000,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Myriad Genetics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Myriad Genetics: Celldex Therapeutics, Inc. (10.55%), Intellia Therapeutics, Inc. (14.05%), QuidelOrtho Co. (3.65%), Neogen Co. (7.49%), Lantheus Holdings, Inc. (7.74%), NeoGenomics, Inc. (5.71%), Avidity Biosciences, Inc. (10.81%), Twist Bioscience Co. (20.77%), Structure Therapeutics Inc. (8.18%), Neumora Therapeutics, Inc. (10.32%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Myriad Genetics stock? Short selling MYGN is an investing strategy that aims to generate trading profit from Myriad Genetics as its price is falling. MYGN shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Myriad Genetics? A short squeeze for Myriad Genetics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MYGN, which in turn drives the price of the stock up even further. How often is Myriad Genetics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MYGN, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Celldex Therapeutics Short Interest Intellia Therapeutics Short Interest QuidelOrtho Short Interest Neogen Short Interest Lantheus Short Interest NeoGenomics Short Interest Avidity Biosciences Short Interest Twist Bioscience Short Interest Structure Therapeutics Short Interest Neumora Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MYGN) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics